Position:News
Acitretin (CAS NO.: 55079-83-9) with EP8.0 2015-05-27
Eprinocmetin (CAS NO.: 123997-26-2) production with USP36 2015-05-27
(R)-(-)-2-Amino-1-butanol” (CAS No. 5856-63-3) 2015-05-27
Rifaximin(CAS No.80621-81-4) conforms to EP, BP, CP standard. 2015-05-27
Trimebutine maleate(CAS No. 34140-59-5) 2015-05-27
5-Bromopyrimidine (CAS NO.:4595-59-9) 2015-05-27
Sodium Stearyl Fumarate (CAS No. 4070-80-8) has formally put into production in Aug,2008, the monthly output is 1-5 tons, conforms to EP/USP/JP/NF standard. 2015-05-27
Rifapentine(CAS No.61379-65-5) has formally put into production in Aug,2008, the monthly output is 3-3.5 tons, this product is the only patented new anti-tuberculous API. 2015-05-27
Ivermectin(CAS NO. 70288-86-7), as veterinary drug and pesticidal , has completed extension and transform in Apr, 2007, and now our company’s output increased to 9 tons/month. 2015-05-27
the most basis intermediate of Ethambutol Hcl—DL-2-Amino-1-butanol(CAS No.13054-87-0) 2015-05-27
The new product Rifabutin (CAS NO.72559-06-9), which our company has been researched and developed for many years, has been put into production in June,2013. 2015-05-27
The good news is that the most basis intermediate of rifa series API ——Rifamycin S - Sodium (CAS No. 14897-39-3) has been put into production in January. its output is 10 tons/month, therefore, our c 2015-05-27
12 Records